文献速递胸部肿瘤支持与姑息治疗

革兰阴性菌肺炎通过宿主TLR4激活促进非小细胞肺癌转移

Gram-Negative Pneumonia Augments Non-Small Cell Lung Cancer Metastasis through Host Toll-like Receptor 4 Activation.
PubMed 文献 · J Thorac Oncol · 2019-08-02

本研究在C57BL/6与TLR4敲除小鼠中,用大肠杆菌或脂多糖气道接种,结合肝转移模型与活体显微成像,发现革兰阴性菌肺炎经宿主TLR4激活增强H59非小细胞肺癌肝转移与肝窦黏附,并涉及支气管上皮TLR4依赖的白介素-6分泌。

要点

  • 革兰阴性菌肺炎经TLR4激活增强小鼠H59非小细胞肺癌肝转移。
  • TLR4敲除小鼠中感染诱导的肝癌窦黏附显著减弱。
  • 支气管上皮TLR4激活与白介素-6分泌介导肿瘤细胞黏附增强。

核心结论

  • TLR4是革兰阴性菌肺炎增强非小细胞肺癌转移的可行治疗靶点。

研究设计与样本

  • C57BL/6与TLR4敲除小鼠气道接种大肠杆菌或脂多糖,行肝转移实验与活体显微成像。
  • 用支气管上皮细胞与TLR4激活的大肠杆菌或脂多糖共培养制备条件培养基,处理H59非小细胞肺癌细胞行黏附实验。

主要发现

  • 革兰阴性大肠杆菌肺炎通过TLR4激活增强C57BL/6小鼠H59非小细胞肺癌肝转移形成。
  • 感染C57BL/6小鼠较阴性对照肝窦黏附的H59细胞增多,该反应在TLR4敲除小鼠中显著减弱。
  • 气管内注射纯化TLR4激活脂多糖增加H59细胞与小鼠肝窦的体内黏附。
  • H59细胞经支气管上皮条件培养基处理后,对体外细胞外基质蛋白与体内肝窦的黏附增加,机制依赖支气管上皮TLR4激活与白介素-6分泌。

临床怎么用

  • 术后革兰阴性菌肺炎可能通过宿主TLR4促进NSCLC转移,TLR4可作为潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Surgery is essential for cure of early-stage non-small cell lung cancer (NSCLC). Rates of postoperative bacterial pneumonias, however, remain high, and clinical data suggests that post-operative infectious complications confer an increased risk for metastasis. Toll-like receptors (TLRs) mediate the inflammatory response to infection by recognizing evolutionarily conserved bacterial structures at the surface of numerous pulmonary cell types; yet, little is known about how host TLR activation influences NSCLC metastasis. TLR4 recognizes gram-negative bacterium lipopolysaccharide activating the innate immune system. METHODS: C57BL/6 and TLR4 knockout murine airways were inoculated with Escherichia coli or lipopolysaccharide. Hepatic metastasis assays and intravital microscopy were performed. Bronchoepithelial conditioned media was generated through coincubation of bronchoepithelial cells with TLR4 activating Escherichia coli or lipopolysaccharide. Subsequently, H59 NSCLC were stimulated with conditioned media and subject to various adhesion assays. RESULTS: We demonstrate that gram-negative Escherichia coli pneumonia augments the formation of murine H59 NSCLC liver metastases in C57BL/6 mice through TLR4 activation. Additionally, infected C57BL/6 mice demonstrate increased H59 NSCLC in vivo hepatic sinusoidal adhesion compared with negative controls, a response that is significantly diminished in TLR4 knockout mice. Similarly, intratracheal injection of purified TLR4 activating lipopolysaccharide increases in vivo adhesion of H59 cells to murine hepatic sinusoids. Furthermore, H59 cells incubated with bronchoepithelial conditioned medium show increased cell adhesion to in vitro extracellular matrix proteins and in vivo hepatic sinusoids through a mechanism dependent on bronchoepithelial TLR4 activation and interleukin-6 secretion. CONCLUSION: TLR4 is a viable therapeutic target for NSCLC metastasis augmented by gram-negative pneumonia.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Gowing SD, Chow SC, Cools-Lartigue JJ, et al. Gram-Negative Pneumonia Augments Non-Small Cell Lung Cancer Metastasis through Host Toll-like Receptor 4 Activation. J Thorac Oncol. 2019. PMID: 31382038. doi:10.1016/j.jtho.2019.07.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。